Trial intelligence / Profile preview

Safety and Efficacy of Methylene Blue Combinations for Malaria in Children

NCT00354380Phase 2Completed

Sponsor
Heidelberg University
Start
Sep 2006
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of methylene blue in Plasmodium falciparum malaria, sponsored by Heidelberg University. Started Sep 2006; status: completed.

02

Drugs

methylene blue
03

Conditions

Plasmodium falciparum malaria

Beyond the preview

Go deeper on NCT00354380.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00354380.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call